Form 4 holding
Chief Technology Officer
Cartesian Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 62,258
- Estimated value
- $1,047,939
- Report date
- 06 Jan 2025
- Price
- $16.83
- Ownership
- Direct
Metin Kurtoglu - Chief Technology Officer at Cartesian Therapeutics, Inc.
Insider Transactions and Holdings
- Entity type
- Individual
- Role
- Chief Technology Officer
- Issuer symbol
- RNAC on Nasdaq
- Source filings
- Open source filing history
There are no Buy or Sell transactions made by Metin Kurtoglu since 30 May 2025
Holdings reported by Metin Kurtoglu for Cartesian Therapeutics, Inc.
Form 4 holding
Chief Technology Officer
Cartesian Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 79,099
- Estimated value
- $62,488
- Report date
- 10 Dec 2024
- Price
- $0.7900
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Technology Officer
Cartesian Therapeutics, Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 47,400
- Estimated value
- Report date
- 02 Jan 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Metin Kurtoglu for Cartesian Therapeutics, Inc.
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
An asterisk next to the price means the reported price is likely invalid.